Wealthspire Advisors, LLC

Position in MRNA — Moderna, Inc.

CIK 1646247 NEW YORK, NY

Position in MRNA

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$276,828

+$268,795 QoQ

Shares Held

3,953

+1171.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#446

of 758 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Wealthspire Advisors, LLC holds $11,785,631 across 19 Biotechnology names. MRNA ranks #6 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	7,042	$4,390,968
2	GALT	Galectin Therapeutics Inc	721,788	$3,349,096
3	OCUL	Ocular Therapeutix, Inc	162,960	$1,600,267
4	VRTX	Vertex Pharmaceuticals Inc / Ma	1,138	$565,278
5	CORT	Corcept Therapeutics Inc	3,540	$307,803
6	MRNA	Moderna, Inc. This page	3,953	$276,828
7	RNXT	RenovoRx, Inc.	252,525	$247,474
8	MREO	Mereo BioPharma Group plc	765,000	$243,270

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$276,828	3,953	+1171.1%	Shares	Sole	2026-08-11
2025-09-30	$8,033	311	-88.1%	Shares	Sole	2025-11-14
2024-06-30	$309,343	2,605	-4.4%	Shares	Sole	2024-08-08
2024-03-31	$290,376	2,725	-10.0%	Shares	Sole	2024-05-06
2023-12-31	$301,134	3,028	-7.9%	Shares	Sole	2024-02-07
2023-09-30	$339,720	3,289	+88.7%	Shares	Sole	2023-11-06
2023-06-30	$211,774	1,743	+32.6%	Shares	Sole	2023-08-01
2023-03-31	$201,804	1,314	-27.4%	Shares	Sole	2023-05-09
2022-12-31	$325,112	1,810	+54.0%	Shares	Sole	2023-02-14
2022-03-31	$202,405	1,175	+103.3%	Shares	Sole	2022-05-09
2021-09-30	$222,449	578	-79.9%	Shares	Sole	2021-11-15
2021-03-31	$375,826	2,870	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.